Medtronic announced today that the FDA granted 510(k) clearance for its MiniMed Go app for multiple daily injections (MDI).

DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced key clinical data from the virtual 81st annual American Diabetes Association ...

Medtronic MDT continues to grab headlines with respect to its Diabetes management business update. Following two back-to-back European approvals last month for its InPen smart insulin pen as well as ...

The InPen is for use with U-100 Lilly Humalog and Novo Nordisk Novolog rapid-acting insulin and indicated for persons aged 12 years and older. Companion Medical announced the launch of the InPen ...

Please provide your email address to receive an email when new articles are posted on . People with diabetes who have difficulty meeting glycemic targets were better able to manage their glucose ...

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...

A new reusable insulin injector pen combined with a smartphone app that helps insulin-dependent diabetes patients calculate their doses and keeps track of injection data is now available in the United ...

Companion Medical announced that it has received clearance from the Food and Drug Administration (FDA) for a new bolus calculator for fixed dosing and meal estimation to be used with the InPen system.